Cowen Starts AbCellera Biologics (ABCL) at Outperform

February 28, 2023 5:44 AM EST Send to a Friend
Cowen analyst Steven Mah initiates coverage on AbCellera Biologics ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login